arrow
B

Bertram Pitt

university of michigan
H指数:116
被引数:7.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Finerenone benefits in patients with cardio-kidney-metabolic syndrome with or without history of cancer: the FINE-HEART pooled analysis

在有无癌症病史的心肾代谢综合征患者中非奈利酮的获益:FINE-HEART合并分析

2026-08-180
OAAI
Finerenone and apparent treatment-resistant hypertension in heart failure with mildly reduced or preserved ejection fraction

非奈利酮对射血分数轻度降低或保留的心力衰竭患者中表观治疗抵抗性高血压的影响

2026-08-170
OAAI
Optimal serum potassium concentrations in heart failure: an individual patient data meta-analysis

心力衰竭患者的最佳血清钾浓度:一项个体患者数据Meta分析

2026-05-280
PRE
Viral respiratory tract infections in heart failure: the FINEARTS-HF trial

心力衰竭中的病毒性呼吸道感染:FINEARTS-HF试验

2026-05-110
PRE
Outcomes With Finerenone by Baseline Treatment Goals in Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Analysis

在2型糖尿病和慢性肾病中,根据基线治疗目标使用非奈利酮的结局:一项FIDELITY分析

2026-04-240
OAAI
Lifetime benefits of finerenone on cardiorenal morbidity and mortality in chronic kidney disease and type 2 diabetes: a pooled analysis of FIDELIO-DKD and FIGARO-DKD trials

慢性肾脏病和2型糖尿病中非奈利酮对心肾患病率和死亡率的全生命周期获益:FIDELIO-DKD和FIGARO-DKD试验的合并分析

2026-04-070
PRE
Finerenone, polypharmacy, and clinical outcomes in heart failure: pre-specified analysis from the FINEARTS-HF trial

非奈利酮、多药治疗和心力衰竭患者的临床结局:FINEARTS-HF试验的预先指定分析

2026-01-010
OA
Finerenone and Cardiovascular Outcomes According to Baseline Kidney Function in Patients With Heart Failure

Finerenone及根据基线肾功能的心力衰竭患者心血管结局

2025-12-050
PRE
Timing of Cardiovascular and Kidney Benefits with Finerenone in Heart Failure and Chronic Kidney Disease with Type 2 Diabetes

Finerenone在心力衰竭和伴有2型糖尿病的慢性肾脏病中心血管和肾脏获益的时间点

JACC
IF0
2025-11-180
OAAI
Finerenone for Heart Failure and Risk Estimated by the PREDICT-HFpEF Model A Secondary Analysis of FINEARTS-HF

非奈利酮用于心力衰竭及根据PREDICT-HFpEF模型估计的风险:FINEARTS-HF的二次分析

2025-06-011
PRE
Higher Risk of Kidney Failure Associated With Angiotensin Receptor Blockers vs ACE Inhibitors in Patients With Heart Failure

与血管紧张素受体阻滞剂相比,心力衰竭患者发生肾衰竭的风险更高

2025-05-240
PRE
Finerenone Reduces New-Onset Atrial Fibrillation Across the Spectrum of Cardio-Kidney-Metabolic Syndrome The FINE-HEART Pooled Analysis

Finerenone 可降低整个心-肾-代谢综合征谱中的新发心房颤动发生率 FINE-HEART 合并分析

2025-05-012
OAAI
Efficacy and safety of finerenone in patients with an acute change in estimated glomerular filtration rate in the prespecified FIDELITY pool analysis

非奈利酮在预设的FIDELITY合并分析中,对于估算肾小球滤过率急性变化患者的疗效与安全性

2025-04-210
PRE